{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["NF-\u03baB", "TLR2", "Th17", "ozone therapy", "psoriasis"]], "CitationSubset": ["IM"], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "32398953", "DateCompleted": {"Year": "2021", "Month": "11", "Day": "10"}, "DateRevised": {"Year": "2021", "Month": "11", "Day": "10"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2020", "Month": "04", "Day": "06"}], "ELocationID": ["10.7150/ijbs.41940"], "Journal": {"ISSN": "1449-2288", "JournalIssue": {"Volume": "16", "Issue": "11", "PubDate": {"Year": "2020"}}, "Title": "International journal of biological sciences", "ISOAbbreviation": "Int J Biol Sci"}, "ArticleTitle": "Ozone Therapy Attenuates NF-\u03baB-Mediated Local Inflammatory Response and Activation of Th17 Cells in Treatment for Psoriasis.", "Pagination": {"StartPage": "1833", "EndPage": "1845", "MedlinePgn": "1833-1845"}, "Abstract": {"AbstractText": ["Ozone therapy has been widely used to treat many skin diseases, including infections, allergic dermatosis, and skin ulcers. However, its efficacy as a treatment for psoriasis is unclear. In this study, we explored the clinical efficacy and the underlying molecular mechanisms of ozone therapy on psoriasis. We found that topical ozone treatment significantly decreased patients' psoriasis area and severity index (PASI) scores and the expression of psoriasis-associated cytokines in their peripheral blood CD4<sup>+</sup> T cells. In the IMQ-induced psoriasis mouse model, topical ozone treatment significantly inhibited the formation of IMQ-induced psoriasis-like lesions and the expression of psoriasis-associated inflammatory factors. High-throughput sequencing confirmed that IMQ-induced activation of toll-like receptor 2 (TLR2)/ nuclear factor-\u03baB (NF-\u03baB) signaling pathway was significantly suppressed in psoriasis-like lesions after topical ozone treatment. Furthermore, the activation of spleen T helper (Th) 17 cells was blocked in the mouse model; this was associated with the downregulation of cytokines and NF-\u03baB pathways upon topical ozone treatment. Ozone therapy can attenuate local inflammatory reactions and the activation of Th17 cells in psoriasis by inhibiting the NF-\u03baB pathway. Our results show that ozone therapy is effective in treating psoriasis. We recommend further evaluations for its clinical applications."], "CopyrightInformation": "\u00a9 The author(s)."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, Third Xiangya Hospital, Central South University, Changsha, Hunan, China."}], "LastName": "Zeng", "ForeName": "Jinrong", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, Third Xiangya Hospital, Central South University, Changsha, Hunan, China."}], "LastName": "Lei", "ForeName": "Li", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, Third Xiangya Hospital, Central South University, Changsha, Hunan, China."}], "LastName": "Zeng", "ForeName": "Qinghai", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "XiangYa School of Medicine, Central South University, Changsha, Hunan, China."}], "LastName": "Yao", "ForeName": "Yuying", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "XiangYa School of Medicine, Central South University, Changsha, Hunan, China."}], "LastName": "Wu", "ForeName": "Yuqing", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "XiangYa School of Medicine, Central South University, Changsha, Hunan, China."}], "LastName": "Li", "ForeName": "Qinxuan", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, Third Xiangya Hospital, Central South University, Changsha, Hunan, China."}], "LastName": "Gao", "ForeName": "Lihua", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, Third Xiangya Hospital, Central South University, Changsha, Hunan, China."}], "LastName": "Du", "ForeName": "Hongjiao", "Initials": "H"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, Third Xiangya Hospital, Central South University, Changsha, Hunan, China."}], "LastName": "Xie", "ForeName": "Yajie", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, Third Xiangya Hospital, Central South University, Changsha, Hunan, China."}], "LastName": "Huang", "ForeName": "Jinhua", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cell Biology and Anatomy, School of Medicine, and."}, {"Identifier": [], "Affiliation": "Department of Biomedical Engineering, College of Engineering and Computing, University of South Carolina, Columbia, South Carolina."}], "LastName": "Tan", "ForeName": "Wenbin", "Initials": "W"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Dermatology, Third Xiangya Hospital, Central South University, Changsha, Hunan, China."}], "LastName": "Lu", "ForeName": "Jianyun", "Initials": "J"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Australia", "MedlineTA": "Int J Biol Sci", "NlmUniqueID": "101235568", "ISSNLinking": "1449-2288"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "NF-kappa B"}, {"RegistryNumber": "0", "NameOfSubstance": "Oils"}, {"RegistryNumber": "0", "NameOfSubstance": "TLR2 protein, human"}, {"RegistryNumber": "0", "NameOfSubstance": "Toll-Like Receptor 2"}, {"RegistryNumber": "66H7ZZK23N", "NameOfSubstance": "Ozone"}, {"RegistryNumber": "P1QW714R7M", "NameOfSubstance": "Imiquimod"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Administration, Topical"}, {"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": [], "DescriptorName": "Baths"}, {"QualifierName": [], "DescriptorName": "CD4-Positive T-Lymphocytes"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gene Expression Regulation"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["therapeutic use"], "DescriptorName": "Imiquimod"}, {"QualifierName": ["chemically induced"], "DescriptorName": "Inflammation"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": ["metabolism"], "DescriptorName": "NF-kappa B"}, {"QualifierName": ["chemistry", "therapeutic use"], "DescriptorName": "Oils"}, {"QualifierName": ["administration & dosage", "therapeutic use"], "DescriptorName": "Ozone"}, {"QualifierName": ["chemically induced", "therapy"], "DescriptorName": "Psoriasis"}, {"QualifierName": [], "DescriptorName": "Severity of Illness Index"}, {"QualifierName": [], "DescriptorName": "Th17 Cells"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Toll-Like Receptor 2"}], "CoiStatement": "Competing Interests: The authors have declared that no competing interest exists."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Boehncke WH, Schon MP. Psoriasis. Lancet. 2015;386:983\u201394.", "ArticleIdList": ["26025581"]}, {"Citation": "Zeng J, Luo S, Huang Y, Lu Q. Critical role of environmental factors in the pathogenesis of psoriasis. The Journal of dermatology. 2017;44:863\u201372.", "ArticleIdList": ["28349593"]}, {"Citation": "Becher B, Pantelyushin S. Hiding under the skin: Interleukin-17-producing gammadelta T cells go under the skin? Nature medicine. 2012;18:1748\u201350.", "ArticleIdList": ["23223063"]}, {"Citation": "Krueger JG. Hiding under the skin: A welcome surprise in psoriasis. Nature medicine. 2012;18:1750\u20131.", "ArticleIdList": ["23223064"]}, {"Citation": "Gutcher I, Becher B. APC-derived cytokines and T cell polarization in autoimmune inflammation. The Journal of clinical investigation. 2007;117:1119\u201327.", "ArticleIdList": ["PMC1857272", "17476341"]}, {"Citation": "Wu R, Zeng J, Yuan J, Deng X, Huang Y, Chen L. et al. MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation. The Journal of clinical investigation. 2018;128:2551\u201368.", "ArticleIdList": ["PMC5983326", "29757188"]}, {"Citation": "Kagami S, Rizzo HL, Lee JJ, Koguchi Y, Blauvelt A. Circulating Th17, Th22, and Th1 cells are increased in psoriasis. The Journal of investigative dermatology. 2010;130:1373\u201383.", "ArticleIdList": ["PMC2892169", "20032993"]}, {"Citation": "Speeckaert R, van Geel N, Lambert J, Claeys L, Delanghe JR, Speeckaert MM. Secukinumab: IL-17A inhibition to treat psoriatic arthritis. Drugs of today (Barcelona, Spain: 1998) 2016;52:607\u201316.", "ArticleIdList": ["28112279"]}, {"Citation": "Toussirot E. Ixekizumab: an anti- IL-17A monoclonal antibody for the treatment of psoriatic arthritis. Expert opinion on biological therapy. 2018;18:101\u20137.", "ArticleIdList": ["29187009"]}, {"Citation": "Lebwohl MG, Papp KA, Marangell LB, Koo J, Blauvelt A, Gooderham M. et al. Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials. Journal of the American Academy of Dermatology. 2018;78:81\u20139.e5.", "ArticleIdList": ["28985956"]}, {"Citation": "Yan S, Xu Z, Lou F, Zhang L, Ke F, Bai J. et al. NF-kappaB-induced microRNA-31 promotes epidermal hyperplasia by repressing protein phosphatase 6 in psoriasis. Nature communications. 2015;6:7652.", "ArticleIdList": ["PMC4506511", "26138368"]}, {"Citation": "Hara-Chikuma M, Satooka H, Watanabe S, Honda T, Miyachi Y, Watanabe T. et al. Aquaporin-3-mediated hydrogen peroxide transport is required for NF-kappaB signalling in keratinocytes and development of psoriasis. Nature communications. 2015;6:7454.", "ArticleIdList": ["PMC5628617", "26100668"]}, {"Citation": "Begon E, Michel L, Flageul B, Beaudoin I, Jean-Louis F, Bachelez H. et al. Expression, subcellular localization and cytokinic modulation of Toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin. European journal of dermatology: EJD. 2007;17:497\u2013506.", "ArticleIdList": ["17951129"]}, {"Citation": "Choudhary V, Uaratanawong R, Patel RR, Patel H, Bao W, Hartney B. et al. Phosphatidylglycerol Inhibits Toll-Like Receptor-Mediated Inflammation by Danger-Associated Molecular Patterns. The Journal of investigative dermatology. 2019;139:868\u201377.", "ArticleIdList": ["PMC7309510", "30391260"]}, {"Citation": "Bialoszewski D, Pietruczuk-Padzik A, Kalicinska A, Bocian E, Czajkowska M, Bukowska B. et al. Activity of ozonated water and ozone against Staphylococcus aureus and Pseudomonas aeruginosa biofilms. Medical science monitor: international medical journal of experimental and clinical research. 2011;17:Br339\u201344.", "ArticleIdList": ["PMC3539485", "22037737"]}, {"Citation": "Zanardi I, Burgassi S, Paccagnini E, Gentile M, Bocci V, Travagli V. What is the best strategy for enhancing the effects of topically applied ozonated oils in cutaneous infections? BioMed research international. 2013;2013:702949.", "ArticleIdList": ["PMC3825054", "24282818"]}, {"Citation": "Ouf SA, Moussa TA, Abd-Elmegeed AM, Eltahlawy SR. Anti-fungal potential of ozone against some dermatophytes. Brazilian journal of microbiology: [publication of the Brazilian Society for Microbiology] 2016;47:697\u2013702.", "ArticleIdList": ["PMC4927674", "27287337"]}, {"Citation": "Jenerowicz D, Silny W, Danczak-Pazdrowska A, Polanska A, Osmola-Mankowska A, Olek-Hrab K. Environmental factors and allergic diseases. Annals of agricultural and environmental medicine: AAEM. 2012;19:475\u201381.", "ArticleIdList": ["23020042"]}, {"Citation": "Gershwin LJ. Comparative immunology of allergic responses. Annual review of animal biosciences. 2015;3:327\u201346.", "ArticleIdList": ["25422854"]}, {"Citation": "Di Paolo N, Gaggiotti E, Galli F. Extracorporeal blood oxygenation and ozonation: clinical and biological implications of ozone therapy. Redox report: communications in free radical research. 2005;10:121\u201330.", "ArticleIdList": ["16156950"]}, {"Citation": "Bocci V, Zanardia I, Valacchi G, Borrelli E, Travagli V. Validity of Oxygen-Ozone Therapy as Integrated Medication Form in Chronic Inflammatory Diseases. Cardiovascular & hematological disorders drug targets. 2015;15:127\u201338.", "ArticleIdList": ["26126818"]}, {"Citation": "Polydorou O, Halili A, Wittmer A, Pelz K, Hahn P. The antibacterial effect of gas ozone after 2 months of in vitro evaluation. Clinical oral investigations. 2012;16:545\u201350.", "ArticleIdList": ["21331635"]}, {"Citation": "Borges GA, Elias ST, da Silva SM, Magalhaes PO, Macedo SB, Ribeiro AP. et al. In vitro evaluation of wound healing and antimicrobial potential of ozone therapy. Journal of cranio-maxillo-facial surgery: official publication of the European Association for Cranio-Maxillo-Facial Surgery. 2017;45:364\u201370.", "ArticleIdList": ["28169044"]}, {"Citation": "Zeng J, Lu J. Mechanisms of action involved in ozone-therapy in skin diseases. International immunopharmacology. 2018;56:235\u201341.", "ArticleIdList": ["29414657"]}, {"Citation": "Wu D, Tan W, Zhang Q, Zhang X, Song H. Effects of ozone exposure mediated by BEAS-2B cells on T cells activation: a possible link between environment and asthma. Asian Pacific journal of allergy and immunology. 2014;32:25\u201333.", "ArticleIdList": ["24641287"]}, {"Citation": "Delgado-Roche L, Martinez-Sanchez G, Re L. Ozone oxidative preconditioning prevents atherosclerosis development in New Zealand White rabbits. Journal of cardiovascular pharmacology. 2013;61:160\u20135.", "ArticleIdList": ["23222311"]}, {"Citation": "Reich K, Gooderham M, Thaci D, Crowley JJ, Ryan C, Krueger JG. et al. Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial. Lancet. 2019;394:576\u2013586.", "ArticleIdList": ["31280967"]}, {"Citation": "van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD. et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. Journal of immunology. 2009;182:5836\u201345.", "ArticleIdList": ["19380832"]}, {"Citation": "van der Fits L, Mourits S, Voerman JS, Kant M, Boon L, Laman JD. et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis. Journal of immunology (Baltimore, Md: 1950) 2009;182:5836\u201345.", "ArticleIdList": ["19380832"]}, {"Citation": "English P, Balmes J. Associations between Ozone and Fine Particulate Matter and Respiratory Illness Found to Vary between Children and Adults. Implications for U.S. Air Quality Policy. American journal of respiratory and critical care medicine. 2019;199:817\u20139.", "ArticleIdList": ["PMC6444659", "30485120"]}, {"Citation": "Apte MG, Buchanan IS, Mendell MJ. Outdoor ozone and building-related symptoms in the BASE study. Indoor air. 2008;18:156\u201370.", "ArticleIdList": ["18333994"]}, {"Citation": "Balmes JR. Long-term Exposure to Ozone and Cardiopulmonary Mortality: Epidemiology Strikes Again. American journal of respiratory and critical care medicine. 2019;200:958\u2013959.", "ArticleIdList": ["PMC6794103", "31185178"]}, {"Citation": "Bocci V, Di Paolo N. Oxygen-ozone therapy in medicine: an update. Blood purification. 2009;28:373\u20136.", "ArticleIdList": ["19752547"]}, {"Citation": "Wei A, Feng H, Jia XM, Tang H, Liao YY, Li BR. Ozone therapy ameliorates inflammation and endometrial injury in rats with pelvic inflammatory disease. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2018;107:1418\u201325.", "ArticleIdList": ["30257358"]}, {"Citation": "Tasdemir Z, Oskaybas MN, Alkan AB, Cakmak O. The effects of ozone therapy on periodontal therapy: A randomized placebo-controlled clinical trial. Oral diseases. 2019;25:1195\u2013202.", "ArticleIdList": ["30739369"]}, {"Citation": "Qin G, Huang J, Pan Y, Xiang Y, Ou C, Huang J. et al. [Topical ozone application: An innovative therapy for infantile atopic dermatitis] Zhong nan da xue xue bao Yi xue ban. 2018;43:163\u20137.", "ArticleIdList": ["29559600"]}, {"Citation": "Lu J, Li M, Huang J, Gao L, Pan Y, Fu Z. et al. [Effect of ozone on Staphylococcus aureus colonization in patients with atopic dermatitis] Zhong nan da xue xue bao Yi xue ban. 2018;43:157\u201362.", "ArticleIdList": ["29559599"]}, {"Citation": "Travagli V, Zanardi I, Valacchi G, Bocci V. Ozone and ozonated oils in skin diseases: a review. Mediators of inflammation. 2010;2010:610418.", "ArticleIdList": ["PMC2910505", "20671923"]}, {"Citation": "Tan L, Huang J, Lu J, Lu J. [Clinical efficacy of ozonated oil in the treatment of psoriasis vulgaris] Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018;43:173\u20138.", "ArticleIdList": ["29559602"]}, {"Citation": "Liu Y, Yin H, Zhao M, Lu Q. TLR2 and TLR4 in autoimmune diseases: a comprehensive review. Clinical reviews in allergy & immunology. 2014;47:136\u201347.", "ArticleIdList": ["24352680"]}, {"Citation": "Begon E, Michel L, Flageul B, Beaudoin I, Jean-Louis F, Bachelez H. et al. Expression, subcellular localization and cytokinic modulation of Toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin. European journal of dermatology: EJD. 2007;17:497\u2013506.", "ArticleIdList": ["17951129"]}, {"Citation": "Candia L, Marquez J, Hernandez C, Zea AH, Espinoza LR. Toll-like receptor-2 expression is upregulated in antigen-presenting cells from patients with psoriatic arthritis: a pathogenic role for innate immunity? The Journal of rheumatology. 2007;34:374\u20139.", "ArticleIdList": ["17183618"]}, {"Citation": "Shao S, Fang H, Dang E, Xue K, Zhang J, Li B. et al. Neutrophil Extracellular Traps Promote Inflammatory Responses in Psoriasis via Activating Epidermal TLR4/IL-36R Crosstalk. Frontiers in immunology. 2019;10:746.", "ArticleIdList": ["PMC6460719", "31024570"]}, {"Citation": "Kay E, Scotland RS, Whiteford JR. Toll-like receptors: Role in inflammation and therapeutic potential. BioFactors (Oxford, England) 2014;40:284\u201394.", "ArticleIdList": ["24375529"]}, {"Citation": "Mahla RS, Reddy MC, Prasad DV, Kumar H. Sweeten PAMPs: Role of Sugar Complexed PAMPs in Innate Immunity and Vaccine Biology. Frontiers in immunology. 2013;4:248.", "ArticleIdList": ["PMC3759294", "24032031"]}, {"Citation": "Brown J, Wang H, Hajishengallis GN, Martin M. TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. Journal of dental research. 2011;90:417\u201327.", "ArticleIdList": ["PMC3075579", "20940366"]}, {"Citation": "Lee JH, Moon JH, Lee YJ, Park SY. SIRT1, a Class III Histone Deacetylase, Regulates LPS-Induced Inflammation in Human Keratinocytes and Mediates the Anti-Inflammatory Effects of Hinokitiol. The Journal of investigative dermatology. 2017;137:1257\u201366.", "ArticleIdList": ["28257794"]}, {"Citation": "Chen JQ, Szodoray P, Zeher M. Toll-Like Receptor Pathways in Autoimmune Diseases. Clinical reviews in allergy & immunology. 2016;50:1\u201317.", "ArticleIdList": ["25687121"]}, {"Citation": "Lu MC, Zhao J, Liu YT, Liu T, Tao MM, You QD. et al. CPUY192018, a potent inhibitor of the Keap1-Nrf2 protein-protein interaction, alleviates renal inflammation in mice by restricting oxidative stress and NF-\u03baB activation. Redox biology. 2019;26:101266.", "ArticleIdList": ["PMC6614503", "31279986"]}, {"Citation": "Subedi L, Lee JH, Yumnam S, Ji E, Kim SY. Anti-Inflammatory Effect of Sulforaphane on LPS-Activated Microglia Potentially through JNK/AP-1/NF-\u03baB Inhibition and Nrf2/HO-1 Activation. Cells. 2019;8:pii. E194.", "ArticleIdList": ["PMC6406309", "30813369"]}, {"Citation": "Visvanathan S, Baum P, Vinisko R, Schmid R, Flack M, Lalovic B. et al. Psoriatic skin molecular and histopathologic profiles after treatment with risankizumab versus ustekinumab. The Journal of allergy and clinical immunology. 2019;143:2158\u201369.", "ArticleIdList": ["30578873"]}, {"Citation": "Zhou F, Zhu Z, Gao J, Yang C, Wen L, Liu L. et al. NFKB1 mediates Th1/Th17 activation in the pathogenesis of psoriasis. Cellular immunology. 2018;331:16\u201321.", "ArticleIdList": ["29748001"]}, {"Citation": "Deng Y, Chang C, Lu Q. The Inflammatory Response in Psoriasis: a Comprehensive Review. Clinical reviews in allergy & immunology. 2016;50:377\u201389.", "ArticleIdList": ["27025861"]}, {"Citation": "Sancak EB, Turkon H, Cukur S, Erimsah S, Akbas A, Gulpinar MT. et al. Major Ozonated Autohemotherapy Preconditioning Ameliorates Kidney Ischemia-Reperfusion Injury. Inflammation. 2016;39:209\u201317.", "ArticleIdList": ["26282390"]}, {"Citation": "Deng L, Meng W, Li D, Qiu D, Wang S, Liu H. The effect of ozone on hypoxia, hemolysis and morphological change of blood from patients with aortic dissection (AD): a preliminary experiment of ozonated autohemotherapy for treating AD. American journal of translational research. 2018;10:1829\u201340.", "ArticleIdList": ["PMC6038082", "30018723"]}, {"Citation": "Chen H, Yu B, Lu C, Lin Q. The effect of intra-articular injection of different concentrations of ozone on the level of TNF-\u03b1, TNF-R1, and TNF-R2 in rats with rheumatoid arthritis. Rheumatology international. 2013;33:1223\u20137.", "ArticleIdList": ["23052485"]}, {"Citation": "Andreula CF, Simonetti L, De Santis F, Agati R, Ricci R, Leonardi M. Minimally invasive oxygen-ozone therapy for lumbar disk herniation. AJNR American journal of neuroradiology. 2003;24:996\u20131000.", "ArticleIdList": ["PMC7975773", "12748111"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "1", "Day": "12"}, {"Year": "2020", "Month": "3", "Day": "21"}, {"Year": "2020", "Month": "5", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "5", "Day": "14", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "11", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2020", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["32398953", "PMC7211165", "10.7150/ijbs.41940", "ijbsv16p1833"]}}], "PubmedBookArticle": []}